The European Journal of Health Economics

, Volume 6, Issue 1, pp 16–23

Modeling the economic burden of diseases imputable to stress at work

Original Papers

Abstract

This study evaluated the costs of work-related stress in France. Three illnesses—cardiovascular diseases, depression, musculoskeletal diseases and back pain—that may result from exposure to stress are identified and the proportions of cases attributable to the risk factor are calculated from epidemiological studies. Two methodological hypotheses allow us to provide complementary evaluations of the social cost of occupational stress and raise the ethical questions inherent in the choice of methodology. For the year 2000 our model shows that of a working population of 23.53 million in France some 310,000–393,400 persons (1.3–1.7%) were affected by illnesses attributable to work-related stress, and that 2,300–3,600 persons died as a result of their illness. Work-related stress costs society between €1,167 million and €1,975 million in France, or 14.4–24.2% of the total spending of social security occupational illnesses and work injuries branch.

Keywords

Occupational stress Attributable fractions method Cost of illness analysis 

References

  1. 1.
    Behrens C, Henke KD (1988) Cost of illness studies: no aid to decision making? Reply to Shiell et al. Health Policy 10:137–141CrossRefPubMedGoogle Scholar
  2. 2.
    CNAMTS/DRP (2002) Statistiques financières et technologiques des accidents du travail. ParisGoogle Scholar
  3. 3.
    Cooper CL (1985) Organisation du travail et stress d’origine professionnelle. In: Automatisation, organisation du travail et stress d’origine professionnelle. BIT: GenèveGoogle Scholar
  4. 4.
    Cour des Comptes (2002) La gestion du risque accidents du travail et maladies professionnelle. FebruaryGoogle Scholar
  5. 5.
    Dhondt S (1998) Time constraints and autonomy at work in the European Union. European Foundation for the Improvement of Living and Working Conditions: DublinGoogle Scholar
  6. 6.
    Drummond M (1992) Cost-of-Illness studies. A major headache? Pharmacoeconomics 2:1–4PubMedGoogle Scholar
  7. 7.
    Drummond M, O’Brien B, Stoddard G, Torrance G (1997) Methods for the economic evaluation of health care programs, 2nd edn. Oxford University Press: OxfordGoogle Scholar
  8. 8.
    Everson SA, Siobhan CM, Lynch JW, Kaplan GA (2002) Epidemiologic evidence for the relation between socioeconomic status and depression, obesity, and diabetes. J Psychosom Res 53:891–895CrossRefPubMedGoogle Scholar
  9. 9.
    Gollac M, Volkoff S (2000) Les conditions de travail. La Découverte, Repères: ParisGoogle Scholar
  10. 10.
    Greenberg PE, Stiglin LE, Finkelstein SN, Berndt ER (1993) The economic burden of depression in 1990. J Clin Psychiatry 54:405–418PubMedGoogle Scholar
  11. 11.
    Hodgson TA (1989) Cost of illness studies: no aid to decision making? Comments on the second opinion by Shiell et al. Health Policy 11:57–60CrossRefPubMedGoogle Scholar
  12. 12.
    Hoogendoorn W, Poppel MV, Bongers P, Koes B, Bouter L (2000) Systematic review of psychosocial factors at work and private life as risk factors for back pain. Spine 25:2114–2125CrossRefPubMedGoogle Scholar
  13. 13.
    Imbernon E (2003) Estimation du nombre de cas de certains cancers attribuables à des facteurs professionnels en France. Institut de Veille Sanitaire, Département Santé-TravailGoogle Scholar
  14. 14.
    Institut National de la Santé et de la Recherche Publique (INSERM) (2002) Statistiques des causes médicales de décès. INSERM: ParisGoogle Scholar
  15. 15.
    Karasek R (1979) Job demands, job decision latitude, and mental strain: Implications for job redesign. Administrative Sci Q 24:285–308Google Scholar
  16. 16.
    Karasek R, Theorell L (1990) Health work stress, productivity and reconstruction of working life. Wiley: New-YorkGoogle Scholar
  17. 17.
    Kind P, Sorensen J (1993) The costs of depression. Int Clin Psychopharmacol 7:191–195PubMedGoogle Scholar
  18. 18.
    Koopmanschap MA, Van Ineveld BM (1992) Towards a new approach for estimating indirect costs of disease. Soc Sci Med 34:1005–1010CrossRefGoogle Scholar
  19. 19.
    Kopp P, Fenoglio P (2002) Social cost of drugs in France. Eur Addict Res DecemberGoogle Scholar
  20. 20.
    Kortt MA, Langley PC, Cox ER (1998) A review of cost-of-illness studies on obesity. Clin Ther 20:772–779CrossRefPubMedGoogle Scholar
  21. 21.
    Le-Pape A, Lecomte T (1996) Aspects socio-économiques de la dépression—Evolution 1980–81/1991–92. CREDES: ParisGoogle Scholar
  22. 22.
    Le-Pape A, Lecomte T (1999) Prévalence et prise en charge de la dépression—France 1996–1997. CREDES: ParisGoogle Scholar
  23. 23.
    Le-Pen C, Lévy P (1995) Le cot des maladies cardiovasculaires. In: Gangjbakhch I, Ollivier J, Pavie A (eds) Maladie coronaire, approches stratégiques et thérapeutiques. Blackwell: ParisGoogle Scholar
  24. 24.
    Letouzey J-P, Genet A, Amoretti R (1996) Cardiologie 2000: Livre Blanc sur la prise en charge des maladies cardiovasculaires en France. Sanesco: ParisGoogle Scholar
  25. 25.
    Levi L, Lunde-Jensen P (1996) A model for assessing the costs of stressors at national level, socio-economic costs of work stress in two EU member states. European Foundation for the Improvement of Living and Working Conditions: Dublin p. 82Google Scholar
  26. 26.
    Mark TL, Woody GE, Juday T, Kleber HD (2001) The economic costs of heroin addiction in the United States. Drug Alcohol Depend 61:195–206CrossRefPubMedGoogle Scholar
  27. 27.
    Meltzer D (1997) Accounting for future costs in medical cost-effectiveness analysis. J Health Econ 16:33–64CrossRefPubMedGoogle Scholar
  28. 28.
    Mireux D (2002) Harmonisation des données de la protection sociale et prévention des troubles musculo-squelettiques en Europe. Rev Med Assurance Maladie 33:67–78Google Scholar
  29. 29.
    Niedhammer I, Goldberg M, Leclerc A, David S, Bugel I (1998) Psychosocial factors at work and subsequent depressive symptoms in the gazel cohort. Scand J Work Environ Health 24:197–205PubMedGoogle Scholar
  30. 30.
    Paoli P, Merllie D (2001) Third European survey on working conditions 2000. European Foundation for the Improvement of Living and Working Conditions: DublinGoogle Scholar
  31. 31.
    Patten SB (2003) International differences in major depression prevalence: what do they mean? J Clin Epidemiol 56:711–716CrossRefPubMedGoogle Scholar
  32. 32.
    Ramaciotti D, Perriard J (2001) Les cots du stress en Suisse. Groupe de Psychologie Appliquée de l’université de Neuchâtel & ERGOrama: GenèveGoogle Scholar
  33. 33.
    Schnall PL, Belkic KL, Landsbergis PA, Baker DB (2000) The workplace and cardiovascular disease. Occup Med 15:324Google Scholar
  34. 34.
    Shiell A, Gerard K, Donaldson C (1987) Cost of illness studies: no aid to decision making? Health Policy 8:317–323CrossRefGoogle Scholar
  35. 35.
    Siegrist J (1996) Adverse health effects of high-effort/low reward conditions. J Occup Health Psychol 1:27–41CrossRefPubMedGoogle Scholar
  36. 36.
    Stoudemire A, Frank R, Hedemark N (1986) The economic burden of depression. Gen Hosp Psychiatry 8:387–394CrossRefPubMedGoogle Scholar
  37. 37.
    Tollefson G, Souetre E, Thomander L, Potvin J (1993) Comorbid anxious signs ans symptoms in major depression: impact on functional work capacity and comparative treatment outcomes. Int Clin Psychopharmacol 8:281–293PubMedGoogle Scholar

Copyright information

© Springer Medizin Verlag 2004

Authors and Affiliations

  1. 1.Economics and Management LaboratoryUniversity of BurgundyDijonFrance
  2. 2.Economics and Management LaboratoryUniversity of BurgundyDijonFrance
  3. 3.Economics and Management LaboratoryPôle d’Economie et de Gestion, 2 bd Gabriel, BP 26611Dijon cedexFrance

Personalised recommendations